Consortium invests $30m in series-B round for Eyevensys
Boehringer Ingelheim Venture Fund has led a $30m series-B round for France-based Eyevensys, a clinical-stage biotechnology company developing non-viral gene therapies for retinal and other ophthalmic diseases.
More on Expansion
Valar Ventures leads $52m series-A for Bitpanda
Company intends to use the fresh capital to further boost its expansion across Europe and scale up its team
Inflexion-backed Ocorian acquires Newgate
Newgate Compliance is a London-based compliance consultancy and hosted regulatory service
Pelican invests £5m in YourParkingSpace
Typical investments from Pelican are in companies with sustainable profits greater than £1m
BGF invests £6.8m in Appnovation
Both CBGF and BGF made initial investments in Appnovation in July 2019 totalling £8.8m
Latest News
Russmedia Partners buys majority stake in Bergfex
Founders of the online Alpine tourism platform will continue to hold a stake in the business
Valar Ventures leads $52m series-A for Bitpanda
Company intends to use the fresh capital to further boost its expansion across Europe and scale up its team
TDR-backed Buffalo Grill acquires distressed rival Courtepaille
Sale process was initiated by Courtepaille's PE sponsor Intermediate Capital Group, which filed for a receivership procedure in July
Hermes Capital-backed Mattenbach buys FO Group
Switzerland-headquartered Hermes Capital Group acquired Mattenbach in November 2019